David Craig, founder and CEO of Sarcomatrix Therapeutics Corp., has released his book 'The New Rules of Biotech: A Founder’s Guide to Building Great Companies' in hardcover and audiobook formats, joining the previously available paperback and Kindle editions. The hardcover is priced at $29.99, the audiobook is available on Google Play, and the book is published by D. Craig Consulting LLC.
The book addresses the fundamental changes in the biotechnology landscape since 2021, arguing that the old playbook no longer works. According to the press release, capital is more expensive, the FDA bar has moved, and the Inflation Reduction Act has rewritten the economics of drug development before approval. Investors now demand capital efficiency and a clear path to value, rather than funding slide decks and dreams.
Craig draws on his experience founding and running a preclinical biotech company to outline how modern biotech companies are built. Topics include choosing between a platform and an asset, selecting an affordable modality, raising a seed round against milestones, and using non-dilutive capital strategically. The book also covers IND-enabling work, CMC, clinical decisions, term sheets, boards, business development, and exits such as acquisitions and IPOs.
The book is written for founders, institutional investors, board members, and operators. Each chapter includes takeaways for operators and separate insights for investors and advisors, making it useful for both sides of the table. The audiobook format allows listeners to absorb the material on the move.
Craig founded his company partly due to a family connection to RYR-1 related congenital muscular dystrophy, a rare genetic muscle disease. This personal connection informs the book's argument that biotech company building carries a responsibility beyond financial returns.
Craig emphasized the importance of offering multiple formats: "The hardcover is there for the people who want a durable copy on the desk, the paperback and Kindle for everyone else, and the audiobook on Google Play for those who prefer to listen on the move. The message is the same across all of them: build for the market that exists now, not the one that existed in 2021."
The availability of 'The New Rules of Biotech' in hardcover and audiobook expands access to its guidance for leaders navigating the current biotech environment. The book is available for purchase on Amazon and Google Play, with prices ranging from $11.99 for the Kindle edition to $29.99 for the hardcover.
For more information, the original press release can be viewed at newmediawire.com.
